viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

Bendall, S.C. et al. A deep profiler's guide to cytometry. Trends Immunol. 33, 323–332 (2012).

Petilla Interneuron Nomenclature Group. et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9, 557–568 (2008).

Irish, J.M. et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217–228 (2004).

Sachs, K. et al. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308, 523–529 (2005).

Majeti, R., Park, C.Y. & Weissman, I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1, 635–645 (2007).

Tarnok, A., Ulrich, H. & Bocsi, J. Phenotypes of stem cells from diverse origin. Cytometry A 77, 6–10 (2010).

O'Brien, C.A., Kreso, A. & Dick, J.E. Cancer stem cells in solid tumors: an overview. Semin. Radiat. Oncol. 19, 71–77 (2009).

Bandura, D.R. et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal. Chem. 81, 6813–6822 (2009).

Cornett, D.S. et al. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods 4, 828–833 (2007).

Mercer, J. et al. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2, 1036–1047 (2012).

Ozsolak, F. & Milos, P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12, 87–98 (2011).

Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57–63 (2009).

Dalerba, P. et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 29, 1120–1127 (2011).

Lubeck, E. & Cai, L. Single-cell systems biology by super-resolution imaging and combinatorial labeling. Nat. Methods 9, 743–748 (2012).

Benoist, C. & Hacohen, N. Immunology. Flow cytometry, amped up. Science 332, 677–678 (2011).

Bendall, S.C. & Nolan, G.P. From single cells to deep phenotypes in cancer. Nat. Biotechnol. 30, 639–647 (2012).

Herzenberg, L.A. et al. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681–685 (2006).

Qiu, P. et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886–891 (2011).

Qian, Y. et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 78 (suppl. 1), S69–S82 (2010).

Pyne, S. et al. Automated high-dimensional flow cytometric data analysis. Proc. Natl. Acad. Sci. USA 106, 8519–8524 (2009).

Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687–696 (2011).

Van der Maaten, L. & Hinton, G. Visualizing (2579–2605): data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).

Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759–806 (2003).

van Lochem, E.G. et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin. Cytom. 60, 1–13 (2004).

Wakita, S. et al. Mutations of the epigenetics modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia. Leukemia published online doi: 10.1038/leu.2012.317 (8 November 2012).

Campana, D. Status of minimal residual disease testing in childhood haematological malignancies. Br. J. Haematol. 143, 481–489 (2008).

Borowitz, M.J. et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111, 5477–5485 (2008).

Ossenkoppele, G.J., van de Loosdrecht, A.A. & Schuurhuis, G.J. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms. Br. J. Haematol. 153, 421–436 (2011).

Loken, M.R. et al. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group. Blood 120, 1581–1588 (2012).

Bodenmiller, B. et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30, 858–867 (2012).

Van der Maaten, L., Postma, E. & Van Den Herik, H. Dimensionality reduction: A comparative review. J. Mach. Learn. Res. 10, 1–41 (2009).

Blondel, V.D. et al. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).

Kotecha, N., Krutzik, P.O. & Irish, J.M. Web-based analysis and publication of flow cytometry experiments. Curr. Protoc. Cytom. 10, 10.17 (2010).